French biotech company Transgene (Euronext Paris: TNG) has appointed Anne Stehlin as chief quality officer and responsible ...

The Alzheimer’s disease (AD) market across the eight major markets (8MM USA, France, Germany, Italy, Spain, UK, Japan, and ...

A San Diego biotechnology company developing oral small molecule medicines for immunology, led by a selective IGF-1R inhibitor targeting thyroid eye disease, an indication currently served only by ...

A biotechnology company creating therapeutics that transform diseased cells into coordinators of cure. Sonata’s machine learning-based platform takes the guesswork out of drug discovery by providing ...

A clinical stage biotech company that focuses on orphan diseases and engages in R&D, manufacturing and commercialization of innovative pharmaceutical products. The company's lead program, LM-030, a ...

A Chinese biotech company developing medicines for people with serious liver diseases. Hexaell Biotech, founded in 2015 in Shanghai, specializes in innovative therapies for severe liver diseases, ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) today authorised Onswik (insulin efsitora alfa) for the ...

Boston, USA-based computational drug discovery company Nimbus Therapeutics has made three senior appointments as it expands ...

US clinical-stage biotech Tortugas Neuroscience has announced positive Phase IIb trial results for obuprazine (TRTL-107), the ...

Italy's Sibylla Biotech, an oncology firm developing small-molecule protein degraders that interfere with protein folding, ...

Telix Pharmaceuticals (ASX: TLX) began US commercial supply of Pixclara (floretyrosine F 18), while Knight Therapeutics (TSX: ...

US biotech companies Bambusa Therapeutics and Aspen Neuroscience have filed for initial public offerings (IPOs), seeking ...